Trials / Completed
CompletedNCT03348384
[11C]NOP-1A and Cocaine Use Disorders
Linking Nociceptive Opioid Peptide (NOP) Receptors With Relapse in Cocaine Use Disorders
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to compared \[C-11\]NOP-1A binding in recently abstinent cocaine use disorders and controls.
Detailed description
This will allow for understanding brain stress and anti-stress mechanisms that underlie abuse of cocaine in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [C-11] | Radiolabel |
| DRUG | NOP-1A | Tracer |
Timeline
- Start date
- 2014-10-30
- Primary completion
- 2019-02-20
- Completion
- 2019-02-20
- First posted
- 2017-11-20
- Last updated
- 2019-08-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03348384. Inclusion in this directory is not an endorsement.